60 likes | 196 Views
Mesothelioma: your questions and future treatment options. Susie Harden 1/4/11. Future possibilities in Cambridge. First line studies Second line studies Phase 1 studies Biobank: potential for individually tailored treatments in the future?. First line studies coming soon.
E N D
Mesothelioma: your questions and future treatment options Susie Harden 1/4/11
Future possibilities in Cambridge • First line studies • Second line studies • Phase 1 studies • Biobank: potential for individually tailored treatments in the future?
First line studies coming soon • MESO 2: phase II study of adding vorinostat to pemetrexed /cisplatin [this agent is a histone deacetylase inhibitor and acts to ‘unblock’ certain genes in tumour cells • ADAM: Phase II study of pegylated arginine deaminase/placebo [when chemotherapy not indicated in ASS (arginosuccinate synthetase) negative patients. (this agent depletes tumours of an essential amino acid – arginine)]
Secondline studies No standard treatment but re-challenge with pemetrexed if good first time response accepted No imminent trials in Cambridge
Tomotherapy dose-wash diagram Phase 1 studies in Cambridge • S222611 SHINOGI [a dual EGFR and HER2 small molecule inhibitor] • Radiotherapy (your feedback please!)
Over to you! Any questions? Any suggestions?